Stroke, Vol. 37, No. 2. (1 February 2006), pp. 577-617.
The aim of this new statement is to provide comprehensive and timely evidence-based recommendations on the prevention of ischemic stroke among survivors of ischemic stroke or transient ischemic attack. Evidence-based recommendations are included for the control of risk factors, interventional approaches for atherosclerotic disease, antithrombotic treatments for cardioembolism, and the use of antiplatelet agents for noncardioembolic stroke. Further recommendations are provided for the prevention of recurrent stroke in a variety of other specific circumstances, including arterial dissections; patent foramen ovale; hyperhomocysteinemia; hypercoagulable states; sickle cell disease; cerebral venous sinus thrombosis; stroke among women, particularly with regard to pregnancy and the use of postmenopausal hormones; the use of anticoagulation after cerebral hemorrhage; and special approaches for the implementation of guidelines and their use in high-risk populations. (Stroke. 2006;37:577-617.)
Ralph Sacco, Robert Adams, Greg Albers, Mark Alberts, Oscar Benavente, Karen Furie, Larry Goldstein, Philip Gorelick, Jonathan Halperin, Robert Harbaugh, Claiborne Johnston, Irene Katzan, Margaret Kelly-Hayes, Edgar Kenton, Michael Marks, Lee Schwamm, Thomas Tomsick
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association Council on Stroke: Co-Sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline.
Stroke, Syndicated
Comments Off
Dec 152011
Stroke, Vol. 37, No. 2. (1 February 2006), pp. 577-617.
